GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (NSE:MEDANTA) » Definitions » ROCE %

Global Health (NSE:MEDANTA) ROCE % : 20.44% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Global Health's annualized ROCE % for the quarter that ended in Sep. 2024 was 20.44%.


Global Health ROCE % Historical Data

The historical data trend for Global Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health ROCE % Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
ROCE %
4.97 4.33 14.36 16.80 19.35

Global Health Quarterly Data
Mar20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.19 22.11 17.36 17.54 20.44

Global Health ROCE % Calculation

Global Health's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=6996.38/( ( (41159.65 - 5725.55) + (43040.75 - 6177.33) )/ 2 )
=6996.38/( (35434.1+36863.42)/ 2 )
=6996.38/36148.76
=19.35 %

Global Health's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=7882.96/( ( (0 - 0) + (45100.81 - 6528.38) )/ 1 )
=7882.96/( ( 0 + 38572.43 )/ 1 )
=7882.96/38572.43
=20.44 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Health  (NSE:MEDANTA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Global Health ROCE % Related Terms

Thank you for viewing the detailed overview of Global Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health Business Description

Traded in Other Exchanges
Address
Medanta - The Medicity, Sector-38, Gurugram, HR, IND, 122001
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health Headlines

No Headlines